Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P960043/S127

Perclose ProGlide Suture-Mediated Closure System; Prostar XL Percutaneous Vascular Surgical System

Abbott Vascular, Inc. · Decision date Dec 9, 2025

FDA DECISIONP960043/S127

What did the FDA approve?

FDA records P960043/S127 as a supplement to PMA P960043, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Dec 9, 2025.

FDA approval order statement

approval for a manufacturing site located at Synergy Health AST, SRL, B13.1 Street 4, Avenue 1, Coyol Free Zone, Coyol, Alajuela, 20102, Costa Rica for sterilization.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Dec 9, 2025
FDA change category
Location Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P960043/S127
Regulatory pathway
PMA supplement
Product code
MGB
Decision code
APPR
Decision date
Dec 9, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, hemostasis, vascular.

Product code
MGB
FDA device class
3

For the original device and its historical approval scope, see PMA P960043. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P960043 · Original PMA

    PROSTAR 9 FR. PERCUTANEOUS VASCULAR SURGICAL (PVS) SYSTEM

  2. P960043/S127 received

    Application receipt date recorded by FDA.

  3. P960043/S127 · FDA decision

    Normal 180 Day Track No User Fee

  4. P960043/S129 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  5. P960043/S130 · Related supplement

    Perclose ProGuide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  6. P960043/S131 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  7. P960043/S132 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  8. P960043/S133 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  9. P960043/S134 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  10. P960043/S136 · Related supplement

    Perclose ProStyle Suture-Mediated Closure and Repair System

  11. P960043/S128 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System and Perclose ProStyle Suture-Mediated Closure and Repair System

  12. P960043/S137 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

  13. P960043/S138 · Related supplement

    Perclose ProStyle Suture-Mediated Closure and Repair System

  14. P960043/S139 · Related supplement

    Perclose ProGlide Suture-Mediated Closure System; Perclose ProStyle Suture-Mediated Closure and Repair System

Timeline entries are records held by MedtechLedger for P960043. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960043

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Vascular, Inc.PMA approvalApr 30, 1997FDA
Abbott Vascular, Inc.PMA supplementFeb 10, 2026FDA
Abbott Vascular, Inc.PMA supplementFeb 11, 2026FDA
Abbott Vascular, Inc.PMA supplementMar 2, 2026FDA
Abbott Vascular, Inc.PMA supplementApr 1, 2026FDA
Abbott Vascular, Inc.PMA supplementApr 17, 2026FDA
Abbott Vascular, Inc.PMA supplementMay 22, 2026FDA
Abbott Vascular, Inc.PMA supplementJul 14, 2026FDA
Abbott Vascular, Inc.PMA supplementAug 27, 2026FDA
Abbott Vascular, Inc.PMA supplementSep 24, 2026FDA
Abbott Vascular, Inc.PMA supplementOct 26, 2026FDA
Abbott Vascular, Inc.PMA supplementNov 4, 2026FDA

Explore the linked device profile

Other records with product code MGB

Product / regulatory recordCompanyPathwayDecision dateSource
Vasorum, Ltd.PMA supplementOct 30, 2026FDA
Vivasure Medical , Ltd.PMA approvalOct 16, 2026FDA
Cardiva Medical, Inc.PMA supplementSep 10, 2026FDA
Terumo Medical CorporationPMA supplementAug 4, 2026FDA
Cordis US CorporationPMA supplementJun 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Vascular, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
400 Saginaw Dr., Redwood, CA, 94063

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records